Shotwise
Wegovy, Ozempic, Mounjaro
Take control of your GLP-1 treatment journey with Shotwise, the ultimate companion app designed to simplify injection tracking and monitor your progress effortlessly. Shotwise helps you stay consistent, informed, and motivated.
Worldwide Release Date: January 9, 2025
Star Ratings(147 ratings | avg ★ 4.7)
App Store (147 ratings)
Downloads (28 days · iOS + Android)
105
Total Downloads (Play Store)
100+
Last 28 days
Revenue
$563
AR
$6,754
MRR
$1,019
ARR
$12,222
Cash Flow Index
0.6x
Active Subscriptions
707
Active Trials
1
ARPAS
$0.79
Paid Subscriber Share (snapshot)
99.9%
Active Customers
536
New Customers
105
Subscription Penetration
131.9%
ARPU
$1.05
RPD
$1.05
ARPPU
$1.44
LTV
$14
MRR Growth (28d)
+0.0%
Subscriber Growth (28d)
+0.0%
All data is verified through RevenueCat. Last updated: Oct 1, 2026, 10:25:17 PM UTC.
App Screenshots
In-App Pricing
Tech Stack
About This Listing
A GLP-1 shot tracker app, low maintenance, huge market and potential for improvement. Also potential for expanded revenue through GLP-1 affiliates that is a huge opportunity but one I haven’t had the time or bandwidth to explore.
Asking Price
$20,370
Sale Details
Business Operations Started
Jan 2025
Assets Included in Sale
Source Code Included
Post-Sales Support
More apps for sale
Browse Marketplace ↗AbMaxx
FOR SALELast 30 days rev
$49,886
MRR
$17,538
NutrIA – Come Mejor Cada Día
FOR SALELast 30 days rev
$26,675
MRR
$15,959
DailyGlowUp
FOR SALELast 30 days rev
$19,492
MRR
$13,537
Goodie AI: Check Groceries
FOR SALELast 30 days rev
$14,485
MRR
$13,298
GainFrame
FOR SALELast 30 days rev
$3,903
MRR
$2,428
taller
Last 30 days rev
$33,074
MRR
$36,047
